NEW YORK, May 22 – After launching into proteomics last year with the acquisition of Emerald BioStructures and ThermoGen, combinatorial chemistry specialist MediChem is now planning to delve even deeper into the study of proteins, MediChem CEO Michael Flavin said Tuesday.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.